EU begins pilot on decentralized generic drug application clearance
Under the decentralized procedure, the medicines are authorized simultaneously in more than one country. Australia, Canada, Chinese Taipei and Switzerland are participating in the first phase of the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.